South Africa’s Covid-19 vaccine rollout plan has practically changed overnight after a small study’s results showed that the AstraZeneca jab doesn’t provide sufficient protection against mild disease caused by the new SARS-CoV-2 variant, known as 501Y.V2 or B.1.351.
Read more here:: ZA Local News
